Immune thrombocytopenic purpura associated with coronavirus disease 2019 infection in an asymptomatic young healthy patient.

Galván Casas, 2020, Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br J Dermatol, 183, 71, 10.1111/bjd.19163

Wollina, 2020, Curaneous signs in COVID-19 patients: a review, Dermatol Ther, e13549

Han, 2020, Prominent changes in blood coagulation of patients with SARS-CoV-2 infection, Clin Chem Lab Med, 58, 1116, 10.1515/cclm-2020-0188

Humbert, 2020, COVID-19 as a cause of immune thrombocytopenia, Med Mal Infect, 50, 459, 10.1016/j.medmal.2020.05.003

Sadr, 2020, Isolated severe thrombocytopenia in a patient with COVID-19: a case report, IDCases, 21, e00820, 10.1016/j.idcr.2020.e00820

Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with Covid-19, N Engl J Med, e43, 10.1056/NEJMc2010472

Magdi, 2019, Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: a case report and literature, Eur J Case Rep Intern Med, 6, 001155

Goeijenbier, 2012, Review: Viral infections and mechanisms of thrombosis and bleeding, J Med Virol, 84, 1680, 10.1002/jmv.23354

Xu, 2020, Mechanism of thrombocytopenia in COVID-19 patients, Ann Hematol, 1

Vlachoyiannopoulos, 2020, Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19, Ann Rheum Dis, 10.1136/annrheumdis-2020-218009